Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurotherapeutics
Metadata
Title
Inhibition and modulation of γ-secretase for Alzheimer’s disease
Author
Michael S. Wolfe
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 3/2008
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1016/j.nurt.2008.05.010

Other articles of this Issue 3/2008

Neurotherapeutics 3/2008 Go to the issue

Abstract

Abstracts from the ASENT 2008 Annual Meeting March 6–8, 2008

Review Article

Ketone bodies as a therapeutic for Alzheimer’s disease

Review Article

New therapeutic targets in the neurovascular pathway in Alzheimer’s disease

Editorial

Novel therapeutics for Alzheimer’s disease

Review Article

Therapeutics for Alzheimer’s disease based on the metal hypothesis

Review Article

Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer’s disease